BioCentury
ARTICLE | Clinical News

N91115: Phase Ib data

October 19, 2015 7:00 AM UTC

Top-line data from a double-blind, U.S. Phase Ib trial in 51 CF patients with 2 copies of the delta F508 CF transmembrane conductance regulator ( CFTR) mutation showed that twice-daily 50, 100 and 200...